Do you want to read an article? Please log in or register.
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment
Further Publications
Related content
Hepatitis
Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
Hepatology
Li J, Xu L, Rui F, Tran S, Tsai PC, Tan Y, Toyoda H, Zeng QL, Trinh H, Hsu YC, Watanabe T, Abe H, Motoyama H, Yoshimaru Y, Suzuki T, Arai T, Atsukawa M, Vutien P, Marciano S, Bai X, Ni W, Geng N, Tseng CH, Liu J, Mi Y, Liu J, Ye Y, Zhu L, Chen RY, Zhu C, Maeda M, Liu JK, Henry L, Yeh ML, Huang CF, Huang JF, Dai CY, Gadano A, Cheung R, Chuang WL, Enomoto M, Tanaka Y, Aishima S, Yu ML, Wu C, Shi J, Nguyen MH
doi: 10.1097/HEP.0000000000001442
HepatologyFurther Publications
All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease
J Hepatol
Huang SC, Su TH, Tseng TC, Hsu SJ, Hong CM, Lan TY, Liu CH, Yang HC, Liu CJ, Kao JH
doi: 10.1016/j.jhep.2024.12.009
Hepatitis
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
N Engl J Med
Hou J, Zhang W, Xie Q, Hua R, Tang H, Morano Amado LE, Yang SS, Peng CY, Su WW, Chuang WL, Kim DJ, Avihingsanon A, Kao JH, Leerapun A, Yuen MF, Asselah T, Liang X, Bo Q, Canducci F, Catanese MT, Chen E, Cheng C, Chughlay F, Das S, Glavini K, Guerreiro N, Huang Y, Kakrana P, Kazma R, Patil A, Pavlovic V, Surujbally B, Triyatni M, Upmanyu R, Wat C, Gane E, Piranga Study Group
doi: 10.1056/NEJMoa2405485
Hepatitis
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Stockdale AJ, Holt B, Bhadoria AS, Sadasivan A, Ikeda D, Pollack T, Ong JP, Pham T, Duong DB, Nguyen V, Ndow G, Chou R, Easterbrook P
doi: 10.1016/S2468-1253(25)00163-3
HepatitisHepatology
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis
J Hepatol
Degasperi E, Anolli MP, Jachs M, Reiberger T, De Ledinghen V, Metivier S, D'Offizi G, di Maria F, Schramm C, Schmidt H, Zöllner C, Tacke F, Dietz-Fricke C, Wedemeyer H, Papatheodoridi M, Papatheodoridis G, Carey I, Agarwal K, Van Bömmel F, Brunetto MR, Cardoso M, Verucchi G, Ciancio A, Zoulim F, Aleman S, Semmo N, Mangia A, Hilleret MN, Merle U, Santantonio TA, Coppola N, Pellicelli A, Roche B, Causse X, D'Alteroche L, Dumortier J, Ganne N, Heluwaert F, Ollivier I, Roulot D, Viganò M, Loglio A, Federico A, Pileri F, Maracci M, Tonnini M, Arpurt JP, Barange K, Billaud E, Pol S, Gervais A, Minello A, Rosa I, Puoti M, Lampertico P
doi: 10.1016/j.jhep.2024.12.044
Hepatitis
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta
J Hepatol
Degasperi E, Scholtes C, Testoni B, Renteria SU, Anolli MP, Charre C, Facchetti F, Plissonnier ML, Sambarino D, Perbellini R, Monico S, Callegaro A, García-Pras E, Lens S, Cortese MF, Forns X, Pérez-Del-Pulgar S, Heil M, Levrero M, Zoulim F, Lampertico P
doi: 10.1016/j.jhep.2024.11.051
RECOMMENDED
Inflammatory Bowel Disease
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Fuentes-Valenzuela E, Bastón-Rey I, García-Alonso FJ, Elosua A, Zabalza San Martín L, Leo Carnerero E, Garcia de la Filia I, Pedraza Pérez A, Sáiz Chumillas RM, Pascual Oliver A, Muñoz Villafranca C, Moreno V, Suárez Ferrer C, Molina G, Ferreiro-Iglesias R, Vega Villaamil P, Gardeazábal Mateos D, Segarra-Ortega JX, Garrido Marín A, Doallo AI, Alonso-Galán H, Brunet-Mas E, Jimenez García N, López Romero-Salazar F, Velayos B, Carballo-Folgoso L, Pérez Santamaría C, Mata Román L, Núñez Ortiz A, Barrio J, Barreiro-de Acosta M, Gutiérrez-Casbas A, Young GETECCU group
doi: 10.1093/ecco-jcc/jjaf058
HepatitisFurther Publications
Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: a systematic review and meta-analysis
BMC Gastroenterol
Lei PK, Liu Z, Ung COL, Hu H
doi: 10.1186/s12876-024-03414-5
Inflammatory Bowel Disease
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study
J Crohns Colitis
Loftus EV Jr, D'Haens G, Louis E, Regueiro M, Jairath V, Magro F, Nakase H, Dubcenco E, Lacerda AP, Ford S, Feng T, Duncan B, Fish I, Cunneen C, Anyanwu SI, Aponte F, Griffith J, Blumenstein I
doi: 10.1093/ecco-jcc/jjaf138